- Home
- HKPD vs NAII Comparison
HKPD vs NAII Comparison
Compare HKPD & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKPD
- NAII
- Stock Information
- Founded
- HKPD 2016
- NAII 1980
- Country
- HKPD Hong Kong
- NAII United States
- Employees
- HKPD N/A
- NAII N/A
- Industry
- HKPD Other Pharmaceuticals
- NAII Medicinal Chemicals and Botanical Products
- Sector
- HKPD Health Care
- NAII Health Care
- Exchange
- HKPD Nasdaq
- NAII Nasdaq
- Market Cap
- HKPD 20.9M
- NAII 21.2M
- IPO Year
- HKPD 2025
- NAII 1987
- Fundamental
- Price
- HKPD $1.21
- NAII $3.71
- Analyst Decision
- HKPD
- NAII
- Analyst Count
- HKPD 0
- NAII 0
- Target Price
- HKPD N/A
- NAII N/A
- AVG Volume (30 Days)
- HKPD 8.9M
- NAII 4.5K
- Earning Date
- HKPD 01-01-0001
- NAII 09-26-2025
- Dividend Yield
- HKPD N/A
- NAII N/A
- EPS Growth
- HKPD N/A
- NAII N/A
- EPS
- HKPD N/A
- NAII N/A
- Revenue
- HKPD $20,313,818.00
- NAII $125,483,000.00
- Revenue This Year
- HKPD N/A
- NAII N/A
- Revenue Next Year
- HKPD N/A
- NAII N/A
- P/E Ratio
- HKPD N/A
- NAII N/A
- Revenue Growth
- HKPD 21.72
- NAII 4.39
- 52 Week Low
- HKPD $0.81
- NAII $2.57
- 52 Week High
- HKPD $3.79
- NAII $6.88
- Technical
- Relative Strength Index (RSI)
- HKPD 49.24
- NAII 49.64
- Support Level
- HKPD $1.00
- NAII $3.58
- Resistance Level
- HKPD $1.76
- NAII $4.03
- Average True Range (ATR)
- HKPD 0.26
- NAII 0.11
- MACD
- HKPD 0.00
- NAII -0.03
- Stochastic Oscillator
- HKPD 15.43
- NAII 28.89
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.